In Doc-resistant prostate cancer cells, HES1 is upregulated as part of a broader activation of the Notch signaling pathway [52], which also involves increased NOTCH2 and Hedgehog signaling. The gene discussed is NOTCH2; the disease is prostate carcinoma.